Target intelligence / Profile preview

G protein subunit gamma 7 (GNG7)

Target
GNG7
Molecular classification
G protein subunit (gamma), Signal transduction protein, Component of heterotrimeric GTPase complex (part of GPCR signaling pathway)
01

Overview

G protein subunit gamma 7 is an integral component of heterotrimeric G proteins, partnering with alpha and beta subunits to mediate signal transduction from GPCRs at the cell membrane. The gamma 7 subunit is essential for proper assembly and stoichiometry of G protein complexes, especially in neural tissue such as striatal medium spiny neurons, thereby influencing dendritic morphology and synaptic function. In cancer, notably gastric cancer, GNG7 acts as a tumor suppressor: its downregulation promotes cell proliferation and tumor progression, while upregulation induces cell cycle arrest and apoptosis. The gene is regulated with multiple splice variants and subject to post-transcriptional modulation, which impacts its cellular localization and abundance. GNG7’s roles span both physiological brain signaling and pathological processes like cancer, making it a notable biomarker and candidate therapeutic target.

Other names
Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7GNG7GNGT7FLJ00058HG3Bheterotrimeric guanine nucleotide-binding protein 3B
02

Mechanism of action

For potential drugs targeting GNG7: Inhibition of cell proliferation by inducing cell cycle arrest and apoptosis. Physiologically: Transduction of signals from GPCRs through the G protein heterotrimer, contributing to downstream activation/inactivation of effectors like adenylate cyclase.

03

Biological functions

Signal transductionModulation of adenylate cyclase activityRegulation of behavioral responses (e.g., fear)Cell cycle regulationApoptosis induction (especially in cancer contexts)
04

Disease associations

Cancer (including gastric, cervical, esophageal, renal cell carcinoma, breast, and head and neck squamous cell carcinoma)Neurological processes (dendritic signaling, synaptic morphology, addiction)
05

Safety considerations

No direct safety/toxicity liabilities for GNG7-targeted drugs documented (due to lack of direct drugs), but modulating G protein pathways implies risk for broad effects on neural and cardiac physiology, requiring careful assessment in therapeutic contexts
06

Interacting drugs

No directly approved drugs targeting GNG7 are listed in current databases; GNG7 modulation is generally indirect, via upstream GPCRs or pathways
07

Biomarkers

Downregulation of GNG7 mRNA/protein is a biomarker for poor prognosis and increased proliferation in gastric and other cancers

Beyond the preview

Go deeper on G protein subunit gamma 7 (GNG7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G protein subunit gamma 7 (GNG7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call